{"ModuleTitle": "Company Description", "CompanyName": "Cumberland Pharmaceuticals Inc.", "Symbol": "CPIX", "Address": "2525 WEST END AVENUE SUITE 950, NASHVILLE,, Tennessee, 37203, United States of America", "Phone": "615-255-0068", "Industry": "Major Pharmaceuticals", "Sector": "Health Care", "Region": "North America", "CompanyDescription": "Cumberland Pharmaceuticals Inc. (\"Cumberland,\" the \"Company,\" or as used in the\r\ncontext of \"we,\" \"us,\" or \"our\"), is a specialty pharmaceutical company focused\r\non the acquisition, development and commercialization of branded prescription\r\nproducts. Our primary target markets are hospital acute care and\r\ngastroenterology. These medical specialties are characterized by relatively\r\nconcentrated prescriber bases that we believe can be penetrated effectively by\r\nsmall, targeted sales forces. Cumberland is dedicated to providing innovative\r\nproducts that improve the quality of care for patients and address unmet or\r\npoorly met medical needs. We promote our approved products through our hospital\r\nand field sales forces in the United States and are establishing a network of\r\ninternational partners to bring our medicines to patients in their countries.&nbsp;&nbsp;... <a href=\"http://secfilings.nasdaq.com/edgar_conv_html%2f2020%2f03%2f20%2f0001628280-20-003880.html#FIS_BUSINESS\" target=\"_blank\">More</a> ...&nbsp;&nbsp;\r\n", "KeyExecutives": [{"name": "A. J. Kazimi", "title": "Chairman & Chief Executive Officer"}, {"name": "Leo B. Pavliv", "title": "Chief Development Officer & EVP-Operations"}, {"name": "Michael P. Bonner", "title": "CFO, Senior Director-Finance & Accounting"}], "Number_of_employees": ["NO INFO"], "Subsidiaries": ["NO INFO"]}